Stress Urinary Incontinence Clinical Trial
Official title:
A Comparison of the Effect on Stress Urinary Incontinence of Lumbopelvic Stabilisation Exercises and Pelvic Floor Exercises: A Randomised Controlled Trial
The patients diagnosed with stress urinary incontinence and included in the study. According to randomisation plan one group will be instructed by a physiotherapist to perform pelvic flor exercises and the other group will be instructed by the same physiotherapist to perform dynamic lumbopelvic stabilisation exercises.Throughout the study, the women will be followed up to ensure the exercises are performed. The exercises will be applied for approximately 30 mins once a day for a period of 10 weeks.
The females included in the study will be separated into 2 groups in the randomisation plan.
One group will be instructed by a physiotherapist to perform pelvic flor exercises, and the
other group will be instructed by the same physiotherapist to perform dynamic lumbopelvic
stabilisation exercises. After a demonstration by the physiotherapist of how both exercises
should be performed, the women will be requested to perform the exercises under the
supervision of the physiotherapist. The pelvic flor exercise will be in the form of
contraction-release for rapidly contracting muscle fibres, and for slowly contracting muscle
fibres, slow contraction by counting to ten, hold for a count of ten, then gradually relax by
counting to ten. The exercises will start as 5 sets of 10 repetitions per day, then each week
the number of sets will be increased by 5 to reach 30 sets per day, and the exercises will be
continued at this rate of 30 sets per day.
The women who will perform the dynamic lumbopelvic stabilisation exercises will be taught the
basic movement, starting with co-contraction of the transversus abdominis (TA) muscle and
other muscles together with diaphragm breathing, and continuing the exercises with upper and
lower extremity movements together with TA and multifidus contraction. Initially the exercise
position is held for 5-10 secs with 10 repetitions, and as the program advances the time of
holding the position will be extended to 30-45 secs. Throughout the study, the women will be
followed up to ensure the exercises are performed. The exercises will be applied for
approximately 30 mins once a day for a period of 10 weeks.
The Q-Tip test will be used in the evaluation of uretero vesical junction (UVJ) mobility. A
cotton swab lubricated with lidocaine gel will be used in the test. The cotton swab will be
placed from the external urethral meatus and will be slowly pushed towards the bladder until
resistance is felt. This point where resistance is met will be accepted as the UVJ. During
the test, the angle will be measured during maximal strain by drawing the labia to the sides.
The patients diagnosed with stress urinary incontinence and included in the study will be
taught the lumbopelvic stabilisation and pelvic floor exercises in the clinic under the
guidance of the physiotherapist.
Study procedure:
In literature, the physiological effects of the exercises have been reported to emerge 2
weeks after starting and complaints reduce in 6-8 weeks. Therefore the patients will be
instructed to perform the lumbopelvic stabilisation exercises at home, once a day for
approximately 30 mins for a period of 10 weeks. Similarly the pelvic flor exercises will be
performed for 10 weeks, once a day lasting approximately 30 mins. On 2 days a week, the women
in both groups will perform the exercises under the guidance of the physiotherapist in the
clinic. In this way, the necessary follow-up will be applied that the women are performing
the pelvic flor muscle exercises and the lumbopelvic stabilisation exercises correctly and
completely.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04829357 -
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
|
||
Completed |
NCT05493735 -
Lidocaine for Pessary Check Pain Reduction
|
Phase 3 | |
Completed |
NCT04512053 -
A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence
|
Phase 2 | |
Active, not recruiting |
NCT06224335 -
Measurement of Intravaginal and Intra-abdominal Pressure and Pad Test During Sports Activities (SPORTVAGPRES)
|
||
Recruiting |
NCT05304312 -
The Role of Kegel Exercises Book to Improve Treatment in Stress Urinary Incontinence Women
|
N/A | |
Not yet recruiting |
NCT05527665 -
Sexual Fonction and Discomfort in Women After Midurethral Sling Surgery, Using PPSSQ
|
||
Not yet recruiting |
NCT04558762 -
Ten Years Follow-up After Insertion of a MUS (Mid Urethral Sling) Due to Stress Urinary Incontinence
|
||
Withdrawn |
NCT02524366 -
A Study of Transcorporal Versus Standard Artificial Urinary Sphincter Placement
|
N/A | |
Completed |
NCT01924728 -
Efficacy of Magnetic Stimulation for Stress Urinary Incontinence
|
N/A | |
Completed |
NCT01676662 -
Solace European Confirmatory Trial
|
N/A | |
Unknown status |
NCT01455779 -
Lyrette: Renewing Continence Objective and Subjective Efficacy Study
|
N/A | |
Terminated |
NCT01029106 -
Gynecare TVT Secur for the Management of Stress Urinary Incontinence (SUI)
|
N/A | |
Withdrawn |
NCT00573703 -
Laparoscopic Burch Colposuspension Versus Transobturatory Tape for the Treatment of Female Urinary Stress Incontinence
|
Phase 4 | |
Completed |
NCT01123096 -
Is the Cough Stress Test Equivalent to the 24 Hour Pad Test in the Assessment of Stress Incontinence?
|
N/A | |
Completed |
NCT01770691 -
Preliminary Performance Study of the New TIPI Device in the Prevention of Stress Urinary Incontinence
|
N/A | |
Completed |
NCT00234754 -
Trans-Obturator Tape Versus Trans-Vaginal Tape for Stress Urinary Incontinence in Women
|
N/A | |
Completed |
NCT00441454 -
Retropubic vs. Transobturator Tension-free Vaginal Tape
|
N/A | |
Completed |
NCT03985345 -
Prospective Evaluation of the Connected EMY Biofeedback Probe in the Management of Stress Urinary Incontinence.
|
N/A | |
Active, not recruiting |
NCT03671694 -
Laser Vaginal Treatment for SUI
|
N/A | |
Completed |
NCT04097288 -
Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects
|
Phase 1 |